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Background
plicit PDT dosimetry model 3 relies on the measurement of a variable that depends sensitively on a range of the response-Photodynamic therapy ~PDT! is a cancer therapy that uses determining treatment factors. In theory such measurements nonionizing photons and a photosensitizer to treat solid tueliminate the need to measure all other tissue factors explicmors and surface malignancies. 1 The effcacy of PDT depends itly. Variation in the fuorescence emission of a photosension the simultaneous presence of photosensitizer, light, and tizer, for example, can in some instances be correlated with oxygen. Visible light is used to excite the photosensitizer. This tissue response and is thus a leading candidate for implicit excitation initiates a cascade of chemical reactions, involving dosimetry. highly reactive oxygen intermediates that produce cellular At the University of Pennsylvania, we are carrying out damage. 1 clinical trials with PDT for treatment of peritoneal sarcoma, 4 Models for the photodynamic dosimetry offer a quantitamalignant pleural effusion, mesothelioma, and recurrent prostive basis for the improvement of PDT treatment protocols, tate cancer. It is well known that there are substantial variaand require accurate measurements of tissue optical properties tions in drug uptake and light dose distribution in biological for their implementation. In the explicit dosimetry method, 2 systems. 5 Several groups have investigated tissue fuorescence the PDT threshold dose is defned as the minimum number of as a surrogate for actual tissue drug concentration, as a prephotons absorbed by the photosensitizer per unit tissue voldictor of PDT tissue response. [6] [7] [8] [9] In the present study we used ume required to produce tissue necrosis. By contrast, an imbefore-PDT fuorescence as a means to characterize tis-sue drug concentration. We then correlated the laser-induced fuorescence ~LIF! and the nominal injected drug dose with PDT-induced depth of necrosis, and with each other.
Study Design, Materials, and Methods

Mouse Tumor Model
The radiation-induced fbrosarcoma ~RIF! tumor cell line was maintained according to strict protocol of in vitro and in vivo passages as described earlier. 10 For in vivo studies, the RIF tumor was implanted on the shoulders of female C3H mice ~average weight 21.2 g!~Taconic, Germantown, New York! by intradermal injection of 3310 5 cells. Tumors were treated about one week after injection, at a size of about 5 to 7 mm in diameter. At that size, all tumors were free of visible necrosis.
Assessment of PDT Tissue Damage
Mice were injected with 0 (n52), 5 (n53), and 10 (n 53) mg/kg Photofrin ~QLT Phototherapeutics Incorporated Vancouver, B.C., Canada! IV via tail veins. Light was delivered to the tumor 24 hours after drug injection using the emission of a KTP-YAG-pumped Rhodamine 6G dye laser ~Laserscope model XP, San Jose, California! operating at 630 nm with a Microlens output optical fber ~Rare Earth Medical, West Yarmouth, Massachusetts!. The fuence rate was 75 mW/cm 2 , and the total delivered light dose was 30 J/cm 2 . Incident light intensity was measured by standard power meters ~Coherent, Auburn, California!. Prior to PDT, mice were anesthetized by an intraperitoneal injection of ketamine/ xylazine ~175/10 mg/kg!.
To assess the tissue damage by PDT in the RIF murine tumor, we adopted a procedure similar to the work of Fingar et al. 11 At 24 hours after PDT treatment, tumors were excised and fxed. They were cut in half vertically with respect to the skin surface, and stained with hematoxylin-eosin. Measurements of the depth of necrosis from the skin inward were made on a graded reticule ~microns! using light microscopy by our pathologist who was blinded to the injection dose and to the forescence signal. For each excised tumor, three to fve sections were taken near the midline. There were no signifcant variations in the depths of necrosis. We are using the deepest depth of necrosis in each tumor in this work.
Fluorescence/Absorption Spectroscopy
We have developed an apparatus that may be used for both fuorescence and absorption measurements ~Fig. 1!. Incident light for absorption measurements was derived from a lamp source. The instrument was converted into a fuorescence spectrometer by using an interference bandpass flter ~Oriel! to select our desired excitation light @545 nm, ;20 nm fullwidth half maximum ~FWHM!# from the total lamp output. Detection was accomplished using a fber-optic probe made of 32 fbers placed in a line with 0.24-mm separation between their centers. The distance between the source and the frst detection fber was 0.44 mm.
Data analysis algorithms were developed using LabView® graphical programming language ~National Instruments, Austin, Texas!. We estimated the effective attenuation coeffcient m eff of the tumor tissue based on the absorption signals collected by detectors located 1.16 to 5 mm from the source. To solve for m eff , we assumed the diffusion approximation for light transport was valid, and ft our refectance data using the semi-infnite medium approximation 12
Here, I(r) is the refected light intensity at distance r from the source, and A is proportional to the incident light intensity at the entrance into the tumor tissue. Plots of ln@r 2 I(r)# versus r yield m eff as the slope. The optical penetration depth d 51/m eff . Our probe arrangement allowed us to enhance the LIF signals by integrating over several consecutive detectors. In our case, LIF signals from the frst three fbers were used. The fuorescence measurements were typically obtained in less than a second. Approximately 200 nW of light from a tungsten halogen lamp was coupled into the tissue using one 210-mm core diameter multimode source fber. The detection fbers collected the LIF and transported the light emission to the entrance slit of the imaging monochromator ~300 gr/mm, f #54, Acton Research, Acton, Massachusetts!. The spectra were collected before and after light delivery concurrently in the range of 500 to 900 nm using a liquid nitrogen cooled CCD camera ~Princeton Instruments, 16 bit, 24-mm pixel size, 33031100 pixels) that operated at 163 K.
The LIF signal was smoothed and normalized at 615 nm. The normalization corrected for variation of the incident light power. The fuorescence spectra contained a combination of autofuorescence and Photofrin fuorescence. To monitor tissue uptake, the Photofrin fuorescence ~peak 628! was integrated between 615 and 645 nm ~Fig. 2!. In this range, the Photofrin fuorescence was clearly distinguishable from tissue autofuorescence in the control mice @Fig. 3~a!#.
Statistical analysis was performed using routines provided by SPSS ~SPSS Incorporated, Chicago, Illinois! and Excel ~Microsoft Corporation!. makes possible a detailed examination of drug deposition in cells and tumor tissue. 15 We have explored the utility of macroscopic LIF spectroscopy for providing semi-quantitative measures of tissue Photofrin uptake, and we correlated fuorescence measurements with the PDT-induced tissue depth of necrosis. Fig. 3 (a) In-vivo LIF monitoring of tissue Photofrin uptake showing LIF signal increases with the amount of Photofrin injected. The mice were injected with 0, 5, and 10 mg/kg Photofrin, respectively, 24 hours prior to these measurements. (b) Photobleaching of Photofrin immediately after PDT, and partial replenishment of Photofrin LIF after fve hours. The spectra were obtained from a mouse injected with 10 mg/kg Photofrin.
Absolute quantifcation of drug fuorescence is complex and requires attention to photon transport physics and photobiology. Tissue optical properties affect the true light dose at specifc locations below the tissue surface, and can complicate the interpretation of tissue fuorescence measurements. The latter effect arises because the source distribution of excitation light depends on tissue optical properties at the excitation wavelength, and because propagation of the fuorescent photons depends on tissue optical properties at the emission wavelength. Despite these diffculties, absolute determination of drug concentration in a semi-infnite phantom based on LIF has been reported. 16, 17 In-vivo use of these methods is complicated and is under active investigation. 2, 18 For example, in PDT of early stage carcinomas of the esophagus with tetra~meta-hydroxyphynyl!chlorin ~mTHPC!, investigators have found large variations of mTHPC uptake among patients. 8 Fluctuations in the degree of tumor destruction between patients were found to be related to mucosal drug uptake as measured by LIF, 8 suggesting that LIF may be used as a guide for PDT. By using LIF as a measure of tissue photosensitizer concentration, these investigators improved the predictability of PDTinduced tumor destruction. This earlier study suggested that the PDT-induced tissue damage was also dependent on the fuence rate. In the research, we quantify tissue damage by measuring the depth of necrosis at a fxed fuence rate that is commonly used in PDT. 
Depth of Light Penetration
Quantifcation of Tissue Photofrin Uptake
Assuming the drug distribution was uniform, we estimated 19 the source of our fuorescence signal was predominantly from depths of order 0.460.2 mm. Our measured Photofrin fuorescence peak is consistent with what other investigators have observed. 20 In the control mice ~without Photofrin injection!, LIF signals and tissue necrosis were negligible ~Fig. 4!. This is consistent with known observations that conditions with either light or drug alone are not enough to cause tissue necrosis; a combination of the two is required. 21 The Pearson correlation between the injected drug dose and the LIF signals was high with a coeffcient of 0.875. Based on the LIF measurements, we observed that tissue Photofrin uptake may vary with the same injected doses at 5 or 10 mg/kg. In our case it was especially true for mice injected with 5 mg/kg Photofrin ~Fig. 4!. The mice received Photofrin via tail vein injection; success of the injection was readily monitored visually. Therefore, we postulate that variation in tissue Photofrin concentration was largely due to tumor uptake. The sources of variable tumor uptake, which may include factors such as tumor angiogenesis and metabolic level, will require further investigation. However, Figs. 3~a! and 3~b! suggest the background fuorescence in both the tumor and the normal tissue is minimal and is unlikely to be the source of the observed variation. Our data suggest that the pre-PDT LIF intensity is an indicator of average drug concentration in the tumor and is critical for PDT-induced tissue necrosis.
Photobleaching is a well-known phenomenon in PDT. LIF spectroscopy is capable of rapid in-situ monitoring of tissue photosensitizer concentration. The temporal dynamics of photosensitizer bleaching during PDT has been studied 7 and has provided insight about fractionation of the PDT light dose. Such experiments force us to reevaluate treatment protocols on a fundamental level. 22, 23 In this study, we also observed signifcant photobleaching after the PDT in the murine tumor model @Fig. 3~b!#. The maximum photobleaching was about 85%, and interestingly, about 30% of the LIF signals replenished 4 hours after PDT ~data not shown!. The background fuorescence as seen after PDT was small @Fig. 3~a!#, indicating that the fuorescence peak represented the tissue Photofrin uptake.
Comparison of LIF and Drug Dose for Prediction of Depth of Necrosis
The Pearson correlation coeffcient between the nominal drug dose and depth of necrosis was 0.771. The correlation coeffcient increased to 0.941 using LIF signals as a measure of tissue Photofrin concentration. Figure 4 shows the results of linear regression using LIF and injected drug dose with respect to predicting depth of necrosis. The goodness of ft measure R-square is superior for LIF ~0.86! compared to the injected drug dose ~0.59!. While suggestive, we note that our Correlation of In Vivo Photosensitizer . . . sample size is rather small; further work must be done to conclude that LIF is more predictive of the depth of necrosis than the injected drug dose. Finally, we observed variability in depth of tissue necrosis by PDT at the same nominal drug dose ~Fig. 4!. In particular, mouse 4 has much less tissue necrosis than the other mice injected with 5 mg/kg Photofrin ~Fig. 4!. Using LIF spectroscopy, mouse 4 was found to have low tissue Photofrin uptake, possibly accounting for the low degree of necrosis. To rule out the possibility of mouse 4 skewing the statistics, we also calculated the correlation coeffcients omitting mouse 4. The Pearson correlation coeffcients between the nominal drug dose to the depth of necrosis was 0.831. The correlation coeffcient improved to 0.930 using LIF signals as a measure of tissue Photofrin concentration.
Conclusion
Even with our relatively small sample size, we have found that LIF spectroscopy can be used to monitor tissue Photofrin uptake, and can be used to predict tissue depth of necrosis. The results suggest that real time in-situ LIF measurements may facilitate the individualized choice of an optimal PDT drug and light dose. 
